Westbourne Investment Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,809
| Closed | -$365K | – | 87 |
|
|
2024
Q3 | $365K | Hold |
5,809
| – | – | 0.13% | 71 |
|
|
2024
Q2 | $343K | Buy |
5,809
+200
| +4% | +$12.5K | 0.12% | 71 |
|
|
2024
Q1 | $447K | Sell |
5,609
-60
| -1% | -$4.58K | 0.16% | 68 |
|
|
2023
Q4 | $448K | Sell |
5,669
-865
| -13% | -$61.6K | 0.18% | 69 |
|
|
2023
Q3 | $456K | Sell |
6,534
-1,825
| -22% | -$129K | 0.21% | 66 |
|
|
2023
Q2 | $578K | Sell |
8,359
-1,740
| -17% | -$124K | 0.26% | 61 |
|
|
2023
Q1 | $750K | Sell |
10,099
-340
| -3% | -$28.5K | 0.36% | 54 |
|
|
2022
Q4 | $973K | Buy |
10,439
+140
| +1% | +$13.5K | 0.49% | 50 |
|
|
2022
Q3 | $982K | Hold |
10,299
| – | – | 0.52% | 49 |
|
|
2022
Q2 | $954K | Sell |
10,299
-900
| -8% | -$87.8K | 0.59% | 44 |
|
|
2022
Q1 | $1.13M | Sell |
11,199
-1,175
| -9% | -$123K | 0.47% | 46 |
|
|
2021
Q4 | $1.28M | Sell |
12,374
-585
| -5% | -$54.1K | 0.5% | 45 |
|
|
2021
Q3 | $1.1M | Sell |
12,959
-1,905
| -13% | -$160K | 0.5% | 44 |
|
|
2021
Q2 | $1.24M | Sell |
14,864
-2,430
| -14% | -$199K | 0.56% | 42 |
|
|
2021
Q1 | $1.3M | Sell |
17,294
-9,700
| -36% | -$707K | 0.65% | 39 |
|
|
2020
Q4 | $1.84M | Sell |
26,994
-3,095
| -10% | -$201K | 1.08% | 26 |
|
|
2020
Q3 | $1.76M | Sell |
30,089
-18,109
| -38% | -$1.13M | 2.01% | 15 |
|
|
2020
Q2 | $3.13M | Sell |
48,198
-5,140
| -10% | -$324K | 3.86% | 6 |
|
|
2020
Q1 | $3.17M | Sell |
53,338
-918
| -2% | -$61.3K | 2.92% | 9 |
|
|
2019
Q4 | $4.03M | Sell |
54,256
-2,935
| -5% | -$206K | 2.75% | 10 |
|
|
2019
Q3 | $3.61M | Buy |
57,191
+735
| +1% | +$43.6K | 2.69% | 10 |
|
|
2019
Q2 | $3.08M | Sell |
56,456
-35
| -0.1% | -$1.89K | 2.49% | 10 |
|
|
2019
Q1 | $3.05M | Buy |
56,491
+5,230
| +10% | +$323K | 2.33% | 9 |
|
|
2018
Q4 | $3.36M | Buy |
51,261
+739
| +1% | +$55.2K | 2.89% | 7 |
|
|
2018
Q3 | $3.98M | Buy |
50,522
+2,284
| +5% | +$163K | 2.89% | 6 |
|
|
2018
Q2 | $3.1M | Buy |
48,238
+3,675
| +8% | +$242K | 2.67% | 7 |
|
|
2018
Q1 | $2.77M | Sell |
44,563
-2,223
| -5% | -$159K | 2.22% | 8 |
|
|
2017
Q4 | $3.39M | Sell |
46,786
-3,064
| -6% | -$223K | 2.57% | 7 |
|
|
2017
Q3 | $4.05M | Sell |
49,850
-180
| -0.4% | -$14.2K | 3.16% | 6 |
|
|
2017
Q2 | $4.03M | Buy |
50,030
+88
| +0.2% | +$6.95K | 3.28% | 6 |
|
|
2017
Q1 | $3.92M | Sell |
49,942
-427
| -0.8% | -$34.1K | 3.23% | 5 |
|
|
2016
Q4 | $3.98M | Buy |
50,369
+11,910
| +31% | +$964K | 3.47% | 4 |
|
|
2016
Q3 | $3.42M | Buy |
38,459
+1,040
| +3% | +$98.2K | 3.03% | 5 |
|
|
2016
Q2 | $3.58M | Buy |
37,419
+385
| +1% | +$38.4K | 3.24% | 5 |
|
|
2016
Q1 | $3.84M | Sell |
37,034
-42
| -0.1% | -$4.08K | 3.68% | 3 |
|
|
2015
Q4 | $3.63M | Buy |
37,076
+1,825
| +5% | +$179K | 3.5% | 5 |
|
|
2015
Q3 | $3.4M | Buy |
35,251
+795
| +2% | +$83.6K | 3.41% | 4 |
|
|
2015
Q2 | $3.61M | Buy |
+34,456
| New | +$3.52M | 3.29% | 3 |
|
Other funds holding CVS
Westbourne Investment Advisors's CVS Position: Q4 2024 in Review
Westbourne Investment Advisors sold out of CVS Health (CVS) in Q4 2024, closing a stake of 5,809 shares — an estimated $365K sold.
Westbourne Investment Advisors first reported a position in CVS in Q2 2015 and held it in 38 quarters. The position peaked at $4.05M in Q3 2017. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.
- Westbourne Investment Advisors reported no remaining CVS Health position as of Q4 2024 after selling out during the quarter.
- Westbourne Investment Advisors sold 5,809 CVS Health shares in Q4 2024, an estimated $365K.
- Westbourne Investment Advisors first reported a position in CVS Health in Q2 2015 and held it in 38 quarters.
- Westbourne Investment Advisors's CVS Health position peaked at $4.05M in Q3 2017.
- 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.
Based on Westbourne Investment Advisors's 13F filing for Q4 2024, filed 28 Jan 2025.